ursodeoxycholic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boldizhar, OO; Derbak, MA; Ganich, TM; Khramtsova, IO; Lazur, YV | 1 |
| Bebawy, M; Chellappan, DK; de Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Hansbro, PM | 1 |
2 other study(ies) available for ursodeoxycholic acid and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
THE EFFECTIVENESS OF COMPLEX THERAPY WITH THE INCLUSION OF THE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Topics: Administration, Oral; Humans; Immunotherapy; Non-alcoholic Fatty Liver Disease; Pulmonary Disease, Chronic Obstructive; Ursodeoxycholic Acid | 2021 |
Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Cystic Fibrosis; Deoxycholic Acid; Drug Delivery Systems; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Nanomedicine; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Staphylococcus aureus; Ursodeoxycholic Acid | 2018 |